FEBRUARY 18, 2021
Grants Awarded

Extramurally funded research grants awarded to Rogel Cancer Center members

Program Key:
CB - Cancer Biology; CG - Cancer Genetics; CHI - Cancer Hematopoiesis and Immunology; DT - Developmental Therapeutics; HBO - Health Behavior and Outcomes; CEP - Cancer Epidemiology and Prevention; TACR - Translational and Clinical Research
$100K+ Extramural Grants Awarded in January
NCI

Elena Stoffel, M.D.: R24 SubK [Lead PI: David Keren (Inheret, Inc.)] ($1M) "InheRET 3.0: An updated SaaS solution that integrates hereditary disease risk, genetic testing, and education" (CEP)


Other NIH

John Moran, Ph.D. and Jeffrey Kidd, Ph.D.: NIGMS R01 ($1.9M) "Identification of Factors Critical for SINE Retrotransposition" (CG)

Diane Fingar, Ph.D.: NIGMS R01 ($1.4M) "Unexpected role for AMPK and mTORC1 in cellular adaptation to nutrient stress" (CB)


Other External

Zaneta Nikolovska-Coleska, Ph.D.: $445K from Circle Pharma for "Developing of Macrocycles for Targeting Protein–Protein Interactions between DOT1L and MLL Onco-fusion Proteins AF9 and ENL" (DT)

Simpa Salami, MBBS: $420K from Robert Wood Johnson Foundation for "Evolution of Kidney Cancer Metastases: Implications for Surveillance and Targeted Therapy" (TACR)

Arvind Rao, Ph.D. and Jeffrey Hodgin, M.D., Ph.D.: $200K Concept Award from the Department of Defense for “Computational Pathology for Lupus Nephritis" (TACR)
Rogel Cancer Center List of Internal and External Funding Opportunities
We update and maintain a comprehensive list of funding opportunities for cancer research.

Please forward this message to your fellow cancer center colleagues.
M-LINE 800-962-3555 | HEALTH LAB BLOG ROGEL CANCER CENTER INTRANET